Eliglustat Tartrate | m-entrepreneurship.com

Product Name :
Eliglustat Tartrate

Search keywords :
Eliglustat

drugId :
null

Target Vo:
Ceramide glucosyltransferase

Target Vo Short Name :
UGCG

Moa_Name:
Ceramide glucosyltransferase inhibitors

First Approval Country :
United States

First Approval Date Filter:
2014

Origin Company_Name :
Genzyme Corp

Active Company_Name :
Beijing Gloria Tiancheng Pharmaceutical Technology Co Ltd

Active Indication_Name:
Gaucher Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MMP9 Rabbit mAb web
Glucosidase 2 subunit beta Rabbit mAb Protocol
TrkA Antibody: TrkA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to TrkA. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts